poisar

Stock

Upstream Bio, Inc. UPB

$6.83-4.21%

Overview

UPB market data

Price History

UPB price chart · 1M
O
7.08
H
7.08
L
6.81
C
6.83
Vol
10,626.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$7.08
Previous Close
$7.13
Day High
$7.08
Day Low
$6.81
52 Week High
$9.57
52 Week Low
$5.86
7 Day Return
-0.36%
30 Day Return
+6.64%
90 Day Return
-18.25%
1 Year Return
-25.60%
Daily Notional Volume
$72.6K
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$2.66
Diluted earnings per share over the trailing twelve months.
Beta
2.07
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-4,719.0%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$5.85 – $33.68
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $385.8M · P/B 4.32 · P/S 116.15.

Company News

6 captured
JP Morgan Maintains Neutral on Upstream Bio, Raises Price Target to $9Benzinga · Aug 14, 2026, 4:14 PM
Truist Securities Maintains Buy on Upstream Bio, Lowers Price Target to $25Benzinga · Aug 12, 2026, 5:39 PM
Upstream Bio Q2 EPS $(0.73) Beats $(0.76) Estimate, Sales $773.000K Beat $430.714K EstimateBenzinga · Aug 11, 2026, 11:33 AM
8-K filing — Upstream Bio, Inc. (UPB)SEC EDGAR · Aug 11, 2026, 11:05 AM
JP Morgan Downgrades Upstream Bio to Neutral, Lowers Price Target to $8Benzinga · Jun 12, 2026, 1:20 PM
Upstream Bio to Present New Verekitug Data at EAACI 2026, Phase 2 Nasal Polyps Analysis Gets EAACI Oral PresentationBenzinga · Jun 8, 2026, 11:30 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock